相关实验视频

Updated: Jun 4, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

在恶性瘤中使用PD-L1抑制剂阿德布雷利马布的研究进展

Pan Cheng¹, Jichen He¹, Pingping Cheng²

¹Department of Pharmacy, Jingjiang People's Hospital Affiliated to Yangzhou University, Taizhou, China.

Frontiers in oncology

|December 17, 2024

概括

针对编程死亡配体1 (PD-L1) 的免疫检查点抑制剂阿德布雷利马布在治疗广泛阶段小细胞肺癌 (SCLC) 中表现有前途. 它的有效性也在其他癌症中得到探索,将其定位为潜在的新疗法.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

阿德布雷利马布是一种人性化的单克隆抗体,向编程死亡配体1 (PD-L1).
它的功能是作为一种新的免疫检查点抑制剂.
它在扩展阶段的小细胞肺癌 (SCLC) 中已经证明了临床疗效.

研究的目的:

突出阿德布雷利马布在SCLC中的治疗潜力.
审查阿德布雷利马布在其他恶性瘤中的进展情况.
探索正在进行的在不同癌症阶段对阿德布雷利马布的研究.

主要方法:

对阿德布雷利马布的临床数据和研究的审查.
对阿德布雷利马布的作用机制的分析.
探索其在不同类型的癌症中的应用.

主要成果:

阿德布雷利马布在扩展阶段SCLC的第一线治疗中显示出良好的临床疗效.
在非小细胞肺癌,三阴性乳腺癌和食道状细胞癌中观察到积极的结果.
目前正在进行的研究正在评估在不同阶段治疗SCLC的阿德布雷利马布.

结论:

阿德布雷利马布是对SCLC的一个有前途的治疗选择.
它的潜力扩展到其他各种恶性瘤.
进一步的研究支持阿德布雷利马布在癌症治疗中的作用.

关键词:

阿德布雷利马布里姆是什么意思扩散阶段的小细胞肺癌.免疫检查点抑制剂免疫检查点抑制剂恶性瘤恶性瘤编程死亡链条 1 编程死亡链条

更多相关视频

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.